Comparison of outcome in patients with acute myocardial infarction aged >75 years with that in younger patients

The American Journal of Cardiology

Volumn 75, Issue 8, 1995, Pages 573-576

  Devlin, William ^a   Cragg, David ^a   Jacks, Marsha ^a   Friedman, Harold ^a   O'Neill, William ^a   Grines, Cindy ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOLYTIC AGENT; HEPARIN;

ACUTE HEART INFARCTION; AGED; ARTICLE; BLEEDING; CAUSE OF DEATH; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FIBRINOLYTIC THERAPY; GERIATRIC PATIENT; HEART MUSCLE REPERFUSION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; THROMBOSIS; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 0028937016     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)80619-5     Document Type: Article

References (31)

1. Age and the Cardiovascular System
2. Age-specific trends in mortality from ischemic heart disease and cerebrovascular disease in Australia
3. Health Statistics on Older Persons, United States, 1986
4. Characteristics of persons dying of disease of heart: preliminary data from the 1986 National Mortality Followback Survey
5. The use of tissue-type plasminogen activator for acute myocardial infarction in the elderly: results from the Thrombolysis in Myocardial Infarction Phase I, open label studies and the Thrombolysis in Myocardial Infarction Phase II pilot study
6. Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction
7. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
8. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction
9. Candidates for thrombolysis among emergency room patients with acute chest pain
10. Intracoronary streptokinase in clinical practice
11. Hemorrhage and the products of fibrinogen digestion after intracoronaty administration of streptokinase
12. The influence of infarction site and size on the ventricular response to coronary thrombolysis
13. Acute myocardial infarction treated with intracorpnary streptokinase: a report of the Society for Cardiac Angiography
14. Hemorrhage vs rethrombosis after thrombolysis for acute myocardial infarction
15. A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction
16. Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy
17. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction
18. Pathology of the conduction system
19. Cardiomyopamy of the aging human heart: myocyte loss and reactive cellular hypertrophy
20. Pathology of the senescent heart: anatomic observations on 237 autopsy studies of patients 90 to 105 years old
21. Prognostic implications and predictors of enhanced regional wall motion of the noninfarct zone after thrombolysis and angioplasty therapy of acute myocardial infarction
22. Mortality and morbidity rates of patients older and younger than 75 years with acute myocardial infarction treated with intravenous streptokinase
23. CORONARY ATHEROSCLEROSIS AND MYOCARDIAL INFARCTION IN NONAGENARIANS: A RETROSPECTIVE AUTOPSY STUDY
24. The Western Washington Myocardial Infarction Registry and Emergency Department Tissue Plasminogen Activator Treatment Trial
25. The TTOPP study—lessons from an aborted trial
26. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction
27. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction
28. Primary coronary angioplasty for acute myocardial infarction (The Primary Angioplasty Registry)
29. Emergency percutaneous transluminal coronary angioplasty during acute myocardial infarction for patients more than 70 years of age
30. Emergency percutaneous transluminal coronary angioplasty for acute myocardial infarction in patients 70 years of age and older
31. Primary angioplasty is the preferred therapy for women and the elderly with acute myocardial infarction—results of the Primary Angioplasty in Myocardial Infarction (PAMI) trial